Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 20, 2021updated 07 Jan 2022 7:18am

Ventura County Hematology Oncology to use Deep Lens’ clinical trial solution

Deep Lens’ AI-based solution automates the process of identifying potentially eligible participants for clinal trials.

Ventura County Hematology Oncology Specialists has signed an agreement to integrate Deep Lens’ clinical trial matching solution which is based on artificial intelligence (AI).

The practice will also use Deep Lens’ other services as part of the collaboration.

Deep Lens’ software will help in identifying eligible participants for clinal trials effectively and quickly.

It automates the process to identify potentially eligible subjects during diagnosis and then match them to relevant clinical trials.

The AI-based solution will pre-screen the participants from EMR (OncoEMR) of Ventura County Hematology Oncology Specialists and merge the molecular data feeds from Foundation Medicine, Guardant Health, and all pathology feeds for automatic identification of qualified participants for the clinical trials.

Deep Lens sales provider and vice-president Tyrone Richardson said: “The majority of patients diagnosed with cancer are treated by community oncologists, and it is critical to bring more trials to this setting so that patients can receive access to novel therapies in a comfortable, familiar environment, without having to travel or commute to larger medical centres.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

“Ventura is a great example of a community oncology practice that prioritizes clinical research and we’re delighted that we can add value to their program and help more of their patients receive stellar, cutting- edge care.”

The company stated that its pre-screening and clinical trial matching solution is provided to oncology practices for free.

Recently, Deep Lens launched its new Real Time Feasibility tool designed to identify eligible patients and select the efficient study sites in the Deep Lens Unity Network for cancer clinical trials.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy